TNFRSF1B and autoimmune disease: TNFR2 has been recognized as a promising therapeutic target for a broad range of disease conditions, from autoimmune diseases over neurodegenerative diseases, tissue injury and alloimmune responses, such as GvHD, to cancer (7–12, 36–44).